U.S. Food Stock News

Stock Yards Bancorp, Inc. has reported its first-quarter 2026 results, with net interest income rising to US$78.42 million and net income reaching US$36.60 million, alongside higher basic and diluted earnings per share from continuing operations compared with a year earlier. At its 2026 annual meeting, the company pointed to record 2025 results, continued loan and deposit growth, expansion in Kentucky, and its 18th consecutive dividend increase since 2012, underscoring a pattern of growing...

Dividend interest in a nuclear-focused utility Recent media coverage naming Vistra (VST) among the best dividend paying nuclear energy stocks has put fresh attention on the utility, especially as its nuclear assets sit alongside gas, coal, solar, and battery storage operations. See our latest analysis for Vistra. At a share price of $166.58, Vistra has seen recent momentum build, with a 7.14% 1 month share price return and a 29.17% 1 year total shareholder return, while the 3 year total...

In April 2026, Nium announced it had integrated Coinbase to power USDC stablecoin payments across its global platform, using Coinbase for stablecoin infrastructure, wallets, liquidity and regulated custody so clients can move between onchain USDC and fiat payouts across more than 190 countries. This partnership deepens Coinbase’s role as a core payments and custody backbone for banks, fintechs and enterprises seeking to connect stablecoin balances with real-world payment networks and...

AvalonBay Communities recently reported its Q1 2026 results, with revenue coming in slightly below estimates but earnings per share surpassing expectations, alongside modest year-over-year gains in same store economic occupancy and rental income and higher fee revenues. This steady operational picture, marked by occupancy rates above expectations and growing fee income, highlights how AvalonBay is extracting more profit from a relatively stable top line. We’ll now examine how resilient...

What recent performance says about Vir Biotechnology (VIR) Vir Biotechnology (VIR) has attracted attention after a recent 2.6% daily gain, capping a month in which the stock returned about 26.7% and roughly 38.4% over the past 3 months. See our latest analysis for Vir Biotechnology. That recent surge sits within a stronger trend, with a 30 day share price return of 26.7%, a year to date share price return of 79.1%, and a 1 year total shareholder return of 74.4%. However, the 3 and 5 year...

In April 2026, Block, Inc. announced a broadened global partnership with Uber that extends Square’s Uber Eats integration to seven countries and introduces Cash App Pay as a checkout option across Uber and Uber Eats in the United States, alongside new client wins and product launches across its Square and Cash App ecosystems. This cluster of developments highlights Block’s effort to deepen its role in restaurant operations, expand Cash App’s reach among younger users, and showcase Square’s...

If you are wondering whether Bentley Systems at around US$32.83 is starting to look interesting or still feels expensive, the next sections will help you frame that question clearly. Over the past week the share price is down 6.8%, with a 5.6% decline over the past month, and the stock is currently showing a 13.9% decline year to date and a 23.4% decline over the past year. These moves are unfolding against a backdrop where Bentley Systems continues to feature in ongoing coverage as an...

If you are wondering whether Catalyst Pharmaceuticals is priced fairly or still offers value, it helps to start by looking at what the recent share price and fundamentals are actually telling you. The stock last closed at US$29.27, with returns of 12.3% over the past week, 25.1% over the past month, 26.4% year to date, 23.9% over the past year, 72.8% over three years and a very large gain over five years. Recent price moves have been in the spotlight as investors react to ongoing...

Pfizer (PFE) is back in focus after unveiling extensive new oncology data at the American Society of Clinical Oncology meeting and securing FDA Priority Review for a PADCEV plus Keytruda bladder cancer regimen. See our latest analysis for Pfizer. Despite the fresh oncology data and the FDA Priority Review, Pfizer’s share price at US$26.79 has had mixed momentum, with a 6.39% year to date share price return and a 24.66% total shareholder return over the past year, in contrast with weaker three...

On April 20, 2026, BMO Capital Markets initiated coverage on Global Payments Inc., assigning a Market Perform rating and highlighting its evolution into a focused merchant acquiring and commerce enablement platform following divestitures and the Worldpay acquisition. The coverage underscores that Global Payments’ multi-year portfolio reshaping now puts execution on integration, sales productivity, and synergy realization at the center of how investors assess the business. Next, we’ll examine...

Why Hilton Worldwide Holdings (HLT) Is Back On Investors’ Radar Hilton Worldwide Holdings (HLT) has caught investors’ attention after a strong stock run over the past year, alongside reported revenue of US$4,954.0 million and net income of US$1,457.0 million. With year to date total return above 13% and one year total return above 50%, readers are weighing how current pricing lines up with Hilton’s earnings power and the growth of its global hotel platform. See our latest analysis for Hilton...

Without a clear single event driving headlines today, CECO Environmental (CECO) is drawing attention as investors consider its recent share performance, current valuation metrics, and the role of its industrial air and water solutions business. See our latest analysis for CECO Environmental. At a share price of US$64.92, CECO Environmental has seen a 6.51% 1 month share price return and an 8.58% year to date share price return. This sits alongside a very large 1 year total shareholder return...

Wondering if Citigroup is still attractively priced after a strong run, or if most of the easy gains are now behind it? The stock last closed at US$129.14, with a 2.9% decline over the past 7 days, a 20.3% return over 30 days, 8.8% year to date, 94.0% over 1 year, 200.1% over 3 years and 113.1% over 5 years. Recent coverage has focused on Citigroup's position as a major US bank and how investors are reassessing large financial institutions in light of sector wide developments. That backdrop...

If you are asking whether RTX at US$173.38 still offers value after a strong run, this article will walk through what the current price really implies. The stock has pulled back with an 11.4% decline over the last 7 days and an 8.6% decline over the last 30 days, even though the 1 year return sits at 41.3% and the 5 year return at 130.5%. Recent headlines have focused on RTX's position in aerospace and defense and how market sentiment has shifted around companies exposed to those themes...

Builders FirstSource (BLDR) is back on investor radar after recent share price moves. The stock is trading at about $89.88 and has shown mixed returns over the past year across different time frames. See our latest analysis for Builders FirstSource. The recent share price pullback, including a 23.37% 3 month share price return decline and a 26.02% 1 year total shareholder return decline, contrasts with an 82.31% total shareholder return gain over five years. This suggests longer term holders...

Recent performance snapshot DiDi Global (OTCPK:DIDI.Y) has had mixed share performance recently, with a small move higher over the past month but a decline over the past 3 months and year to date. See our latest analysis for DiDi Global. With the share price at US$3.80, DiDi Global’s shorter term share price returns, including a 1 day decline of 1.04% and a 7 day decline of 2.06%, contrast with weaker momentum over the past quarter and year to date. However, the 1 year total shareholder...

Assessing IMAX after recent share price performance IMAX (IMAX) has drawn fresh attention after recent share price moves, with the stock up 1.8% over the past day and 3.3% over the past week, prompting investors to revisit fundamentals. See our latest analysis for IMAX. Beyond the latest move, IMAX’s 90 day share price return of 6.8% and 1 year total shareholder return of 54.9% point to positive momentum that contrasts with the more modest year to date share price return of 3.1%. If recent...

On April 13, 2026, Dauch Corporation’s board approved the termination of Tolga Oal, President – Axle Systems, with his employment ending April 16, 2026. This senior leadership shift in a core operating segment comes just weeks before Dauch’s May 8, 2026 first-quarter results conference call. We’ll now examine how the abrupt removal of the Axle Systems president may influence Dauch’s broader investment narrative and business outlook. Capitalize on the AI infrastructure supercycle with our...

If you are trying to work out whether Hamilton Lane’s current share price lines up with its underlying worth, this is a useful moment to take a closer look at how the stock is valued. The share price closed at US$89.46, with returns of negative 16.3% over the last week, negative 5.6% over 30 days, negative 34.5% year to date and negative 39.6% over the past year, while the 3 year and 5 year returns sit at 29.7% and 9.3% respectively. Recent price moves have sharpened the focus on what...

VeriSign, Inc. reported first‑quarter 2026 results with revenue of US$428.9 million and net income of US$214.5 million, alongside higher earnings per share versus a year earlier. The company paired these stronger results with raised full‑year 2026 guidance for revenue and operating income, plus another US$0.81 per‑share dividend approval, underscoring management’s confidence in its core domain registry business. Next, we’ll examine how the upgraded 2026 revenue and operating income guidance...

Mastercard is extending its Agent Pay and Verifiable Intent technologies to open agent ecosystems through lobster.cash, enabling AI agents to initiate payments using Mastercard credentials. KuCoin is integrating direct crypto payments with Mastercard's global network in Australia, allowing real time, crypto backed transactions at the point of sale. Together, these moves highlight Mastercard's push into AI driven commerce and digital asset payments beyond its traditional card...

Event context and recent performance Hilltop Holdings (HTH) has drawn fresh investor attention after recent share price moves, with the stock last closing at $36.80 and delivering a 4.5% gain over the past month. See our latest analysis for Hilltop Holdings. Recent price momentum has been mixed, with a 4.6% 1 month share price return and an 8.6% year to date share price return, alongside a 29.7% 1 year total shareholder return, which points to earlier strength now consolidating. If you are...

In April 2026, Regeneron Pharmaceuticals and partner Sanofi reported a series of milestones including FDA accelerated approval for Otarmeni, expanded U.S. pediatric approval for Dupixent in chronic spontaneous urticaria, and publication of positive Phase 3 cemdisiran data in generalized myasthenia gravis. These developments underline Regeneron’s push into gene therapy, pediatric immunology, and complement-mediated diseases, broadening its portfolio beyond Eylea while keeping some programs,...

If you are wondering whether Renasant at around US$39.99 is offering fair value or a potential mismatch between price and fundamentals, this article examines what the current share price could be indicating. The stock has returned 13.6% over the last 30 days and 27.0% over the past year, which may have caught your eye if you track Banks stocks or already hold Renasant. Recent coverage around the company has focused on its position within the US regional banking space and how investors are...